Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific for CD47, PD-L1, and uses thereof

Antibodies specific for CD47, PD-L1, and uses thereof

US Patent 11702474 · Granted Jul 18, 2023

Estimated economic value: $390,606,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of enhancing cell survival of stem cells2025
Protease-activating CD45-gate CAR2025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Induction of pluripotent cells2025
Inducible chimeric cytokine receptors2024
Inducible chimeric cytokine receptors2024
Chimeric antigen receptors targeting CD702024
Generation of induced pluripotent cells by CRISPR activation2024
Chemical reprogramming to generate neuronal cells2024
Modified caspase-9 polypeptides and methods of use thereof2024
Generation and maintenance of stem cells2024
Constitutively active chimeric cytokine receptors2024